EBITDA

ThoughtSpot's new suite of BI agents signals a major shift from static reports to autonomous action. But can it overcome the hurdles of trust and adoption?

IDC names Optiv a GRC leader, highlighting a market-wide move from checkbox compliance to integrated, business-driven cybersecurity strategy.

DoubleVerify's new partnership with TikTok promises deeper ad insights, but what does it signal for the future of platform transparency and ad spend?

A new partnership seeks to unify viewership, channel, and ad data across all 210 US markets, promising unprecedented precision for local advertisers.

Beyond holiday safety tips, a Texas company's innovative simulation training offers a resilient business model for an increasingly anxious public.

A new report reveals a surprising twist in the AI era: personal recommendations now drive book discovery, as social reading and audiobooks surge.

With a massive lodge expansion and an all-inclusive dining plan, the cruise line is making a strategic play to dominate the lucrative Alaska land-tour market.

The 2025 proxy season saw record director support as investors prioritized financials, yet dissent over executive pay signals a new battleground.

Beyond the dazzling lights, Seattle's iconic New Year's Eve show is a calculated investment in branding, technology, and regional economic dominance.

ADP's new retirement plan isn't just about lower fees. It's a tech-driven strategy to solve the SMB benefits gap and empower financial advisors.

Beyond sugar and spice, America's historic hotels are using elaborate gingerbread displays as a calculated investment in brand equity and holiday revenue.

Daré Bioscience is targeting a 20M-woman market with a novel arousal cream. This is the story of its clever regulatory strategy and high-stakes bet.

Beyond philanthropy, KinderCare's alumni scholarship is a strategic investment in its brand, building a human capital pipeline from the ground up.

With a key FAA filing, Electra's hybrid-electric EL9 moves closer to reality, promising to bypass airports with 150-foot takeoffs and landings.

Promising data for NuCana's NUC-7738 offers hope for tough-to-treat melanoma, but the biotech's financial health presents a critical hurdle.

The space firm secures vital cash through a complex warrant deal, but at what cost to shareholders? All eyes are now on a critical investor vote.

With department stores gone, Primaris REIT is betting on a new model: mixed-use hubs with high-value tenants. Is this the future of Canadian retail?

Beyond the hype, additive manufacturing is now a force in the skies. Discover how Stratasys and Airbus are using it to build lighter, greener, faster jets.

With new clinical data and recent FDA approval, IceCure Medical's tumor-freezing tech is paving a new, less-invasive path for breast cancer treatment.

A new partnership aims to commercialize Arbli™, the first liquid losartan, leveraging a digital platform to solve patient adherence and capture market share.